Heart registry for patients after coronary interventions in South East Netherlands

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to create a comprehensive registry for patients undergoing percutaneous coronary intervention (PCI) for chronic and acute coronary syndromes. It focuses on assessing the quality of secondary prevention and personalized medicine strategies to reduce the risk of ischemic events post-PCI. By analyzing various risk factors such as thrombotic, lipid, inflammation, and diabetic factors, the study seeks to improve patient outcomes through tailored treatment plans. The registry will collect data to enhance understanding and management of residual risks associated with coronary artery disease.

Why it matters

Who can join: the full rules

No in- or exclusion criteria are applied to gain 100% registration in order to prevent bias.

Where it's running

• ZuyderlandMC
  Heerlen, Limburg, Netherlands Recruiting
• MaastrichtUMC+
  Maastricht, Limburg, Netherlands Recruiting
• VieCuri
  Venlo, Limburg, Netherlands Recruiting
• Radboud University Medical Centre
  Nijmegen, Netherlands Recruiting

Study contacts

• Study coordinator: van Geuns
• Email: robertjan.vangeuns@radboudumc.nl
• Phone: (024) 3614153

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI-driven Medipixel fractional flow reserve to guide PCI

  This test checks whether an AI-based, angiography-derived Medipixel FFR method can guide PCI as safely and effectively as standard invasive pressure-wire FFR in adults with coronary artery disease.

  Recruiting at 23 sites Samsung Medical Center · Seoul, Select State and 22 other locations · NCT07329699

• Common femoral vein-to-artery diameter ratio to detect elevated LVEDP

  Researchers test whether the ratio of the common femoral vein to artery diameters, measured by ultrasound, can flag elevated LV end-diastolic pressure in patients having coronary angiography.

  Recruiting Burapha University · Chon Buri · NCT07866859

• Aspirin 50 mg vs 100 mg with a P2Y12 inhibitor after PCI

  This trial tests whether a 50 mg daily aspirin dose, when used with a P2Y12 inhibitor after PCI, works as well as 100 mg with similar safety for people staying on DAPT for 12 months.

  Recruiting Jilin University · Changchun, Jilin · NCT07846462

• Can CZT-SPECT/CT quantify myocardial tracer uptake to match PET measurements in coronary artery disease?

  This study tests whether CZT-SPECT/CT can quantify heart blood flow at rest and stress and see if the results align with PET measurements for people with coronary artery disease.

  Recruiting Centre Hospitalier Régional d'Orléans · Orléans, Loiret · NCT07708805

• Microplastics and nanoplastics in people with chronic coronary syndromes

  This study will test whether tiny plastic particles (micro- and nanoplastics) can be detected in the coronary blood of adults with suspected or known chronic coronary syndromes who are having coronary CT and invasive angiography.

  Recruiting at 2 sites Azienda Ospedaliera "Sant'Andrea" · Caserta and 5 other locations · NCT07291609

• Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions

  This trial tests whether the Freesolve resorbable magnesium scaffold works as well as the Xience drug-eluting stent for treating up to two new coronary artery lesions in adults.

  Recruiting at 3 sites Teleflex · Washington D.C., District of Columbia and 2 other locations · NCT07258290

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.